Primary Ciliary Dyskinesia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Primary Ciliary Dyskinesia Market is segmented By Treatment (Pharmacological Therapy, Gene Therapy, ...

Primary Ciliary Dyskinesia Market Size

Market Size in USD Mn

CAGR5.7%

Study Period2025-2032
Base Year of Estimation2024
CAGR5.7%
Market ConcentrationMedium
Major PlayersParion Sciences, ReCode Therapeutics, Vertex Pharmaceuticals, Reata Pharmaceuticals, Arrowhead Pharmaceuticals and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Primary Ciliary Dyskinesia Market Analysis

The primary ciliary dyskinesia market is estimated to be valued at USD 568.9 Mn in 2025 and is expected to reach USD 838.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. The market is witnessing positive trends with many pharmaceutical companies actively working on developing targeted treatments for primary ciliary dyskinesia (PCD).

Primary Ciliary Dyskinesia Market Report Snapshots